Clinical Research Directory
Browse clinical research sites, groups, and studies.
PET Imaging of 68Ga-NOTA-H006 in Malignancy
Sponsor: YiHui Guan
Summary
5T4, also known as trophoblast glycoprotein, is an oncofoetal antigen expressing in fetal development and cancer but rarely in adult. The high expression of 5T4 in malignancy was found be associated with poor clinical outcomes in ovarian, gastric and colorectal cancers. Several antibody drug conjugates are currently under development for cancer therapy in preclinic and clinic stages. Previously, investigators engineered a 5T4-specific biomolecule with nanomolar binding affinity. Radiolabeling with gallium-68 resulted in 68Ga-NOTA-H006 which showed 5T4 expression in a variety of xenograft models. Thus, the aims of current study are to evaluate the distribution and dosimetry of this novel tracer, and to explore the diagnostic values of 68Ga-NOTA-H006 in malignant tumors.
Official title: A Study to Evaluate 5T4 Expression in Malignant Tumors Using 68Ga-NOTA-H006
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
15
Start Date
2023-12
Completion Date
2028-12
Last Updated
2023-12-08
Healthy Volunteers
No
Conditions
Interventions
68Ga-NOTA-H006 is injected intravenously with a dose of 1.8 MBq[0.05MCi]/kg.
68Ga-NOTA-H006:PET imaging; 18F-FDG:PET imaging
Locations (1)
Huashan Hospital
Shanghai, China